Trulieve Makes History With First NYSE Cannabis Listing

LifestyleVicesTrulieve Makes History With First NYSE Cannabis ListingByA.J. Herrington,Contributor.Forbes contributors publish independent expert analyses and insights. A.J. Herrington is a freelance writer covering weed news and culture.Follow AuthorJun 05, 2026, 12:27pm EDTTrulieve's upcoming NYSE listing follows the Trump administration's decision to reclassify medical marijuana under federal law.gettyMultistate operator Trulieve, one of the nation’s largest cannabis companies, announced on Friday that the company’s subordinate voting shares have been approved for uplisting to the New York Stock Exchange next week. The impending uplisting comes following the Trump administration’s recent reclassification of medical marijuana under federal drug laws, the most significant change in federal cannabis policy in more than half a century. The subordinate voting shares are expected to begin trading on the NYSE under the symbol "TRLV" at the opening of trading on June 10, 2026, the company said in a statement. “As the first U.S. cannabis company to list on a major U.S. exchange, we are excited for the opportunity to expand our shareholder base, increase liquidity, and raise awareness for the benefits of medical marijuana. Common sense action by President Trump to reclassify medical marijuana to Schedule III paved the way for this historic milestone,” Kim Rivers, founder and CEO of Trulieve, said in a statement from the company. “Uplisting to the NYSE is a major advancement for Trulieve and the industry.” Feds Announced Cannabis Rescheduling In April After Acting Attorney General Todd Blanche announced in April that state-licensed medical marijuana and FDA-approved cannabis drugs would be reclassified to Schedule III of the Controlled Substances Act, Trulieve initiated a corporate restructuring that included an investment from a third party. The move resulted in a deconsolidation of the company’s operations in markets serving both medical and adult use...